Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |